Scleroderma, Idea Development Award (DOD)

• Published date: 06 August 2020
• Date: 06 August 2020
• DOI: http://doi.org/10.1002/fgc.31218

Page 4 Federal Grants & Contracts ■ August 6, 2020

© 2020 Wiley Periodicals LLC • All rights reserved • DOI: 10.1002/fgc

Grants alert (cont.)

data collection from living and dead stranded marine

mammals; scientic research objectives designed to

answer questions about marine mammal strandings,

health or rehabilitation techniques utilizing data from

living and dead stranded marine mammals; and facility

operations directly related to the recovery, treatment and

data collection from living and dead stranded marine

mammals.

Deadline: Oct. 13, 2020.

Funds: $4 million total for up to 45 awards.

Eligibility: Active, authorized participants or researchers

in the National Marine Mammal Stranding Network or

Entanglement Response Network.

Areas: DOC said objectives include but are not limited

to: improving the rescue, care and treatment of stranded

or entangled marine mammals; reducing the health risk

to animals, humans and the ocean environment during

response to, and rehabilitation and release of, stranded

or entangled marine mammals; collecting life history,

biological and biomedical data from live and dead

stranded or entangled marine mammals; among many

others.

➜ www.grants.gov; FON# NOAA-NMFS-

PRPO-2021-2006563

Flood-Risk Reduction and Nutrient Mediation

in the Mississippi River Basin (DOD)

Scope: The Defense Department’s U.S. Army Corps of

Engineers seeks applications for the Evaluating Non-

oodplain Wetlands (NFWs) for Flood-Risk Reduction

and Nutrient Mediation in the Mississippi River Basin

announcement to assess the water and nutrient yields

resulting from landscape water-storage capacities of

NFWs in the Mississippi River Basin.

Deadline: Statement of Interest, Aug. 20, 2020;

proposals, Sept. 18, 2020.

Funds: $250,000 for one award.

Eligibility: Nonfederal partners of the Gulf Coast

Cooperative Ecosystems Studies Unit.

Areas: DOD said activities include but are not limited

to: Task 1—Collaboratively and Cooperatively Develop

the Quality Assurance Project Plan, Task 2—Develop

High-Resolution Inundation and Flowpath Dataset, Task

3—Develop Parameterized Model and Task 4—Quantify

Watershed-Scale Water and Nutrient Yields, among

many others.

➜ www.grants.gov; FON# W81EWF-20-SOI-0037

Scleroderma Research Program Translational

Research Partnership Award (DOD)

Scope: The Defense Department’s U.S. Army Medical

Research Acquisition Activity seeks applications for

the Scleroderma Research Program Translational

Research Partnership Award announcement to support

partnerships between clinicians and research scientists

that will accelerate the movement of promising ideas in

scleroderma into clinical applications.

Deadline: Pre-applications, Sept. 9, 2020; proposals,

Dec. 4, 2020.

Funds: Approximately $2.4 million for two Translational

Research Partnership Award applications.

Eligibility: Unrestricted.

Areas: DOD said to be considered for funding,

applications must address one of the following FY20

SRP Translational Research Partnership Award Focus

Areas: understanding the different biological/metabolic

pathways that differentiate subsets of patients (gender,

age, genetic, clinical phenotype, race/ethnicity);

utilizing systems biology, multi-omics and preclinical

screening approaches to understand the heterogeneity

of disease, prevention and therapeutics inventions;

and development of cohorts from diverse populations

(longitudinal) to validate potential biomarkers (i.e.,

replication studies); among others.

➜ www.grants.gov; FON# W81XWH-20-SRP-TRPA

Scleroderma, Idea Development Award (DOD)

Scope: The Defense Department’s U.S. Army Medical

Research Acquisition Activity seeks applications for the

Scleroderma, Idea Development Award announcement

to support conceptually innovative high-risk/high-

reward research that could lead to critical discoveries

or major advancements in scleroderma research and/or

improvements in patient care.

Deadline: Pre-applications, Sept. 9, 2020; proposals,

Dec. 4, 2020.

Funds: Approximately $2.4 million for two Idea

Development Award applications and two Idea

Development—New Investigator Collaboration Option

Award applications.

Eligibility: Unrestricted.

Areas: DOD said to be considered for funding,

applications must address one of the following FY20

SRP Idea Development Award Focus Areas: the

development of clinical trial platforms that enable the

rapid comparison of different therapeutic approaches

on a pilot basis; dene biomarkers (omics and/or

molecular markers, cell subsets, imaging, patient-

reported outcomes) that help inform therapeutic choices

(immunosuppressive/anti-brotic) or predict course

(morbidity) and quality of life; and secondary analysis

of scleroderma, and other similar disease datasets,

to identify novel targets and biomarkers that can be

validated in existing or new models.

➜ www.grants.gov; FON# W81XWH-20-SRP-IDA

(more)